The Biden administration has gone all in on the COVID-19 antiviral Paxlovid, announcing new measures to make the oral treatment more widely available and making it clear that Vice President Harris used it as she recovered from the coronavirus.
The White House has said it will nearly double the amount of Paxlovid available around the country and that it is working to set up more Test-to-Treat locations in pharmacies and other locations.
But the administration faces a number of obstacles in really making Paxlovid, and a similar treatment from Merck and Ridgeback known as molnupiravir, easily accessible to Americans.
The Supreme Court sided with a Christian counselor on Tuesday in her free speech challenge to...
A new COVID-19 variant, BA.3.2, has been detected in 25 states, according to a recent report...
The abortion rate is holding steady in the US despite total and partial bans in some...
A New Mexico jury determined Tuesday that Meta knowingly harmed children's mental health and concealed what...
